Fully integrated web-based incubation and imaging system used for protein crystallisation screening and optimisation now available at benchtop scale
Discovery Partners International and Bruker AXS have announced the launch of a bench top version of their popular Crystal Farm product for high-throughput protein crystallisation.
The new Crystal Farm CF-150 employs the same technology as the CF-400 model in a smaller footprint.
The Crystal Farm products have become a market leader in protein crystallisation and imaging for the drug discovery and high throughput crystallography community, says Bruker.
The Crystal Farm is a fully integrated web-based incubation and imaging system used for protein crystallisation screening and optimisation.
By providing high-throughput protein crystallisation automation, Crystal Farm addresses the critical quest for high-speed structure-based drug discovery and design.
The bench top system combines capacity for up to 15,000 simultaneous experimental conditions, with DPI's patent pending Cool Flash imaging technology, and includes a web-browser based interface that controls all system functions either locally or remotely, including priority-based image scheduling, viewing and scoring.
Experimental results stored in a SQL database can be easily mined for monitoring and optimising crystallisation experiments.
"The strategic partnership between Discovery Partners and Bruker AXS has allowed us to provide powerful crystallisation and X-ray diffraction solutions to the drug discovery and structural biology communities," said John Lillig, CTO and vice president of Discovery Partners International.
"The technological leadership of the Crystal Farm, together with Bruker's expertise and marketing presence in X-ray crystallography, has allowed the Crystal Farm to establish a strong position in this dynamic new market".
""The Crystal Farm product has become very popular in large, high-throughput labs, where it produces better quality crystals, more quickly than traditional manual crystallisation techniques.
"We are excited to introduce the bench top model which will make this technology accessible for innovative new applications in smaller-scale laboratories as well," commented Roger Durst, vice president of R and D and global crystallography business manager of Bruker AXS.
